BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 10432417)

  • 1. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
    Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
    Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans.
    Montazerifar F; Hashemi M; Karajibani M; Dikshit M
    J Med Food; 2010 Dec; 13(6):1490-3. PubMed ID: 21091256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men.
    Nyyssönen K; Porkkala-Sarataho E; Kaikkonen J; Salonen JT
    Atherosclerosis; 1997 Apr; 130(1-2):223-33. PubMed ID: 9126668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients.
    Tosukhowong P; Sangwatanaroj S; Jatuporn S; Prapunwattana P; Saengsiri A; Rattanapruks S; Srimahachota S; Udayachalerm W; Tangkijvanich P
    Clin Hemorheol Microcirc; 2003; 29(3-4):321-9. PubMed ID: 14724357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients.
    Morena M; Cristol JP; Bosc JY; Tetta C; Forret G; Leger CL; Delcourt C; Papoz L; Descomps B; Canaud B
    Nephrol Dial Transplant; 2002 Mar; 17(3):422-7. PubMed ID: 11865087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of antioxidant enzymes, plasma vitamins C and E in cement plant workers.
    Aydin S; Aral I; Kilic N; Bakan I; Aydin S; Erman F
    Clin Chim Acta; 2004 Mar; 341(1-2):193-8. PubMed ID: 14967176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia.
    Wittenstein B; Klein M; Finckh B; Ullrich K; Kohlschütter A
    Free Radic Biol Med; 2002 Jul; 33(1):103-10. PubMed ID: 12086688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris.
    Duthie GG; Beattie JA; Arthur JR; Franklin M; Morrice PC; James WP
    Nutrition; 1994; 10(4):313-6. PubMed ID: 8000152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total radical-trapping antioxidant parameter in NIDDM patients.
    Ceriello A; Bortolotti N; Falleti E; Taboga C; Tonutti L; Crescentini A; Motz E; Lizzio S; Russo A; Bartoli E
    Diabetes Care; 1997 Feb; 20(2):194-7. PubMed ID: 9118773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients.
    Roehrs M; Valentini J; Paniz C; Moro A; Charão M; Bulcão R; Freitas F; Brucker N; Duarte M; Leal M; Burg G; Grune T; Garcia SC
    BMC Nephrol; 2011 Oct; 12():59. PubMed ID: 22029620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.
    Clermont G; Lecour S; Lahet J; Siohan P; Vergely C; Chevet D; Rifle G; Rochette L
    Cardiovasc Res; 2000 Aug; 47(3):618-23. PubMed ID: 10963735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
    Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
    Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No indications of persistent oxidative stress in response to an ironman triathlon.
    Neubauer O; König D; Kern N; Nics L; Wagner KH
    Med Sci Sports Exerc; 2008 Dec; 40(12):2119-28. PubMed ID: 18981936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
    Venturini D; Simão AN; Dichi I
    Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
    Baldi S; Innocenti M; Frascerra S; Nannipieri M; Lippi A; Rindi P; Ferrannini E
    J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis.
    Demirci S; Sekeroğlu MR; Noyan T; Köçeroğlu R; Soyoral YU; Dülger H; Erkoç R
    Cell Biochem Funct; 2011 Apr; 29(3):249-54. PubMed ID: 21465497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.